Skip to content
OpenCapital
Get started

Kyntra Bio, Inc. KYNB Q4 2025 Annual earnings

Reported March 16, 2026 · After market close

Revenue$1.3MMiss by $370.0K
EPS-$3.61Beat by $0.28
Revenue estimate$1.7M
EPS estimate-$3.89

Next report

Aug 10, 2026 (In 1 week)
Revenue estimate$2.1M
EPS estimate-$3.18

Versus estimates

Revenue

Q1 2026$3.7MBeat by $2.1M
Q4 2025$1.3MMiss by $370.0K
Q3 2025$1.1MMiss by $594.0KQ2 2025$1.3MMiss by $1.6MQ1 2025$2.7MBeat by $739.0KQ4 2024-$123.3MMiss by $148.2M

Diluted EPS

Q1 2026-$3.74Miss by $0.38
Q4 2025-$3.61Beat by $0.28
Q3 2025-$1.61Beat by $2.40Q2 2025-$3.38Miss by $1.13Q1 2025-$4.00Miss by $4.75Q4 2024-$0.08In line

Ask the moment Kyntra Bio, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Kyntra Bio, Inc. report Q4 2025 earnings?
Kyntra Bio, Inc. (KYNB) reported Q4 2025 earnings on March 16, 2026 after market close.
What were Kyntra Bio, Inc.'s Q4 2025 revenue and EPS?
Kyntra Bio, Inc. reported revenue of $1.3M and eps of $-3.61 for Q4 2025.
Did Kyntra Bio, Inc. beat estimates in Q4 2025?
Revenue missed the consensus estimate of $1.7M by $370.0K. EPS beat the consensus estimate of $-3.89 by $0.28.
How did Kyntra Bio, Inc.'s Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 101.1% from -$123.3M a year earlier and eps declined 4412.5% from $-0.08.
Where can I find Kyntra Bio, Inc.'s Q4 2025 SEC filings?
You can read the 8-K earnings release (0001193125-26-108324) and the 10-K periodic report (0001193125-26-108346) directly on SEC EDGAR. The filing index links above go to sec.gov.